» Articles » PMID: 33523930

1-Methylnicotinamide is an Immune Regulatory Metabolite in Human Ovarian Cancer

Abstract

Immune regulatory metabolites are key features of the tumor microenvironment (TME), yet with a few exceptions, their identities remain largely unknown. Here, we profiled tumor and T cells from tumor and ascites of patients with high-grade serous carcinoma (HGSC) to uncover the metabolomes of these distinct TME compartments. Cells within the ascites and tumor had pervasive metabolite differences, with a notable enrichment in 1-methylnicotinamide (MNA) in T cells infiltrating the tumor compared with ascites. Despite the elevated levels of MNA in T cells, the expression of nicotinamide -methyltransferase, the enzyme that catalyzes the transfer of a methyl group from -adenosylmethionine to nicotinamide, was restricted to fibroblasts and tumor cells. Functionally, MNA induces T cells to secrete the tumor-promoting cytokine tumor necrosis factor alpha. Thus, TME-derived MNA contributes to the immune modulation of T cells and represents a potential immunotherapy target to treat human cancer.

Citing Articles

Spatial mapping of dextran sodium sulphate-induced intestinal inflammation and its systemic effects.

Adams L, Rasid O, Hulme H, Quon T, Burchmore R, Milling S FASEB J. 2025; 39(4):e70415.

PMID: 39989432 PMC: 11848815. DOI: 10.1096/fj.202402780R.


Functional biomaterials for biomimetic 3D in vitro tumor microenvironment modeling.

Ahmed T In Vitro Model. 2025; 2(1-2):1-23.

PMID: 39872875 PMC: 11756483. DOI: 10.1007/s44164-023-00043-2.


Nicotinamide N-methyltransferase negatively regulates metastasis-promoting property of cancer-associated fibroblasts in lung adenocarcinoma.

Wang P, Wang G, Li H, Yuan Y, Chen H, Wang S Cancer Commun (Lond). 2024; 45(2):110-137.

PMID: 39623600 PMC: 11833673. DOI: 10.1002/cac2.12633.


A systematic evaluation of quenching, extraction and analysis procedures for metabolomics study of the mechanism of QYSLD intervention in A549 cells.

Chen C, Zheng T, Chen Y, Li Z, Wu H Anal Bioanal Chem. 2024; 416(28):6621-6638.

PMID: 39467912 DOI: 10.1007/s00216-024-05563-8.


Challenges of Spatially Resolved Metabolism in Cancer Research.

Lane A, Higashi R, W-M Fan T Metabolites. 2024; 14(7).

PMID: 39057706 PMC: 11278851. DOI: 10.3390/metabo14070383.


References
1.
Cronin S, Seehus C, Weidinger A, Talbot S, Reissig S, Seifert M . The metabolite BH4 controls T cell proliferation in autoimmunity and cancer. Nature. 2018; 563(7732):564-568. PMC: 6438708. DOI: 10.1038/s41586-018-0701-2. View

2.
Huang Y, McCarthy D, Stegle O . Vireo: Bayesian demultiplexing of pooled single-cell RNA-seq data without genotype reference. Genome Biol. 2019; 20(1):273. PMC: 6909514. DOI: 10.1186/s13059-019-1865-2. View

3.
Martinez-Reyes I, Chandel N . Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020; 11(1):102. PMC: 6941980. DOI: 10.1038/s41467-019-13668-3. View

4.
Bowtell D, Bohm S, Ahmed A, Aspuria P, Bast Jr R, Beral V . Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer. 2015; 15(11):668-79. PMC: 4892184. DOI: 10.1038/nrc4019. View

5.
Ron-Harel N, Santos D, Ghergurovich J, Sage P, Reddy A, Lovitch S . Mitochondrial Biogenesis and Proteome Remodeling Promote One-Carbon Metabolism for T Cell Activation. Cell Metab. 2016; 24(1):104-17. PMC: 5330619. DOI: 10.1016/j.cmet.2016.06.007. View